138 related articles for article (PubMed ID: 12479388)
1. Microscopic localization of active gelatinases in equine osteochondritis dissecans (OCD) cartilage.
Al-Hizab F; Clegg PD; Thompson CC; Carter SD
Osteoarthritis Cartilage; 2002 Aug; 10(8):653-61. PubMed ID: 12479388
[TBL] [Abstract][Full Text] [Related]
2. Comparison of radiography and ultrasonography for the diagnosis of osteochondritis dissecans in the equine femoropatellar joint.
Bourzac C; Alexander K; Rossier Y; Laverty S
Equine Vet J; 2009 Sep; 41(7):685-92. PubMed ID: 19927588
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
Clegg PD; Carter SD
Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
[TBL] [Abstract][Full Text] [Related]
4. Osteochondritis dissecans of the elbow: histopathological assessment of the articular cartilage and subchondral bone with emphasis on their damage and repair.
Kusumi T; Ishibashi Y; Tsuda E; Kusumi A; Tanaka M; Sato F; Toh S; Kijima H
Pathol Int; 2006 Oct; 56(10):604-12. PubMed ID: 16984617
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD
Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279
[TBL] [Abstract][Full Text] [Related]
6. Chondrocytes harvested from osteochondritis dissecans cartilage are able to undergo limited in vitro chondrogenesis despite having perturbations of cell phenotype in vivo.
Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
J Orthop Res; 2008 Aug; 26(8):1133-40. PubMed ID: 18327793
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
8. Arthroscopic reattachment of osteochondritis dissecans cartilage flaps of the femoropatellar joint: long-term results.
Sparks HD; Nixon AJ; Fortier LA; Mohammed HO
Equine Vet J; 2011 Nov; 43(6):650-9. PubMed ID: 21649712
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
10. Microscopic change in macroscopically normal equine cartilage from osteoarthritic joints.
Weaver RE; Sharif M; Livingston LA; Andrews KL; Fuller CJ
Connect Tissue Res; 2006; 47(2):92-101. PubMed ID: 16754515
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
12. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia.
de Grauw JC; Brama PA; Wiemer P; Brommer H; van de Lest CH; van Weeren PR
Am J Vet Res; 2006 Jul; 67(7):1156-62. PubMed ID: 16817736
[TBL] [Abstract][Full Text] [Related]
13. Osteochondritis dissecans-like lesions of the occipital condyle and cervical articular process joints in a Saddlebred colt horse.
Lim CK; Hawkins JF; Vanderpool AL; Heng HG; Gillespie Harmon CC; Lenz SD
Acta Vet Scand; 2017 Oct; 59(1):76. PubMed ID: 29084574
[TBL] [Abstract][Full Text] [Related]
14. Involvement of mitochondrial dysfunction and ER-stress in the physiopathology of equine osteochondritis dissecans (OCD).
Desjardin C; Chat S; Gilles M; Legendre R; Riviere J; Mata X; Balliau T; Esquerré D; Cribiu EP; Betch JM; Schibler L
Exp Mol Pathol; 2014 Jun; 96(3):328-38. PubMed ID: 24657499
[TBL] [Abstract][Full Text] [Related]
15. Arthroscopic reattachment of osteochondritis dissecans lesions using resorbable polydioxanone pins.
Nixon AJ; Fortier LA; Goodrich LR; Ducharme NG
Equine Vet J; 2004 Jul; 36(5):376-83. PubMed ID: 15253076
[TBL] [Abstract][Full Text] [Related]
16. In vitro phenotypic modulation of chondrocytes from knees of patients with osteochondritis dissecans: implications for chondrocyte implantation procedures.
Aurich M; Hofmann GO; Mückley T; Mollenhauer J; Rolauffs B
J Bone Joint Surg Br; 2012 Jan; 94(1):62-7. PubMed ID: 22219249
[TBL] [Abstract][Full Text] [Related]
17. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis.
Laverty S; Okouneff S; Ionescu M; Reiner A; Pidoux I; Webber C; Rossier Y; Billinghurst RC; Poole AR
J Orthop Res; 2002 Nov; 20(6):1282-9. PubMed ID: 12472241
[TBL] [Abstract][Full Text] [Related]
18. Gene and protein expression of cartilage canal and osteochondral junction chondrocytes and full-thickness cartilage in early equine osteochondrosis.
Riddick TL; Duesterdieck-Zellmer K; Semevolos SA
Vet J; 2012 Dec; 194(3):319-25. PubMed ID: 22627046
[TBL] [Abstract][Full Text] [Related]
19. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP
Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644
[TBL] [Abstract][Full Text] [Related]
20. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
